Neoadjuvant Therapy With Bevacizumab

作者: Thomas Gruenberger , Birgit Gruenberger , Werner Scheithauer

DOI: 10.1200/JCO.2005.05.2910

关键词:

摘要:

参考文章(13)
Fairooz F. Kabbinavar, Julie Hambleton, Robert D. Mass, Herbert I. Hurwitz, Emily Bergsland, Somnath Sarkar, Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer Journal of Clinical Oncology. ,vol. 23, pp. 3706- 3712 ,(2005) , 10.1200/JCO.2005.00.232
Lee M. Ellis, Steven A. Curley, Axel Grothey, Surgical Resection After Downsizing of Colorectal Liver Metastasis in the Era of Bevacizumab Journal of Clinical Oncology. ,vol. 23, pp. 4853- 4855 ,(2005) , 10.1200/JCO.2005.23.754
Timothy Whelan, Mark Levine, Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question Journal of Clinical Oncology. ,vol. 23, pp. 1- 4 ,(2005) , 10.1200/JCO.2005.08.955
Christopher G Willett, Yves Boucher, Emmanuelle di Tomaso, Dan G Duda, Lance L Munn, Ricky T Tong, Daniel C Chung, Dushyant V Sahani, Sanjeeva P Kalva, Sergey V Kozin, Mari Mino, Kenneth S Cohen, David T Scadden, Alan C Hartford, Alan J Fischman, Jeffrey W Clark, David P Ryan, Andrew X Zhu, Lawrence S Blaszkowsky, Helen X Chen, Paul C Shellito, Gregory Y Lauwers, Rakesh K Jain, Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Nature Medicine. ,vol. 10, pp. 145- 147 ,(2004) , 10.1038/NM988
Christopher G Willett, Yves Boucher, Dan G Duda, Emmanuelle Di Tomaso, Lance L Munn, Ricky T Tong, Sergey V Kozin, Lucine Petit, Rakesh K Jain, Daniel C Chung, Dushyant V Sahani, Sanjeeva P Kalva, Kenneth S Cohen, David T Scadden, Alan J Fischman, Jeffrey W Clark, David P Ryan, Andrew X Zhu, Lawrence S Blaszkowsky, Paul C Shellito, Mari Mino-Kenudson, Gregory Y Lauwers, None, Surrogate Markers for Antiangiogenic Therapy and Dose-Limiting Toxicities for Bevacizumab With Radiation and Chemotherapy: Continued Experience of a Phase I Trial in Rectal Cancer Patients Journal of Clinical Oncology. ,vol. 23, pp. 8136- 8139 ,(2005) , 10.1200/JCO.2005.02.5635
Eitaro Taniguchi, Shotaro Sakisaka, Katsuhiko Matsuo, Kyuichi Tanikawa, Michio Sata, Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. Journal of Histochemistry and Cytochemistry. ,vol. 49, pp. 121- 129 ,(2001) , 10.1177/002215540104900112
Geoffrey Chong, David Cunningham, Improving long-term outcomes for patients with liver metastases from colorectal cancer Journal of Clinical Oncology. ,vol. 23, pp. 9063- 9066 ,(2005) , 10.1200/JCO.2005.04.4669
Herbert Hurwitz, Louis Fehrenbacher, William Novotny, Thomas Cartwright, John Hainsworth, William Heim, Jordan Berlin, Ari Baron, Susan Griffing, Eric Holmgren, Napoleone Ferrara, Gwen Fyfe, Beth Rogers, Robert Ross, Fairooz Kabbinavar, None, BEVACIZUMAB PLUS IRINOTECAN, FLUOROURACIL, AND LEUCOVORIN FOR METASTATIC COLORECTAL CANCER The New England Journal of Medicine. ,vol. 350, pp. 2335- 2342 ,(2004) , 10.1056/NEJMOA032691
F. Scappaticci, L. Fehrenbacher, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, F. Kabbinavar, W. Novotny, H. Hurwitz, Lack of effect of bevacizumab on wound healing/bleeding complications when given 28–60 days following primary cancer surgery Journal of Clinical Oncology. ,vol. 22, pp. 3530- 3530 ,(2004) , 10.1200/JCO.2004.22.90140.3530
T. Gruenberger, B. Schuell, G. Kornek, W. Scheithauer, Neoadjuvant chemotherapy for resectable colorectal cancer liver metastases: Impact on magnitude of liver resection and survival Journal of Clinical Oncology. ,vol. 22, pp. 3598- 3598 ,(2004) , 10.1200/JCO.2004.22.90140.3598